Pfizer

Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Pfizer, established in 1849 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Health Care, Medical, Therapeutics, Oncology, Finance, Venture Capital, Life Science, Health Diagnostics, Pharmaceutical. The organization boasts a portfolio of 49 investments, with an average round size of $66.9M and 19 successful exits. Their recent investments include Merus, EQT Life Sciences, Bay City Capital, Novartis Venture Fund, Aureon Laboratories. The highest investment round they participated in was $269.3B. Among their most notable exits are Merus and EQT Life Sciences. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.